Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

The "Obstructive Sleep Apnea - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides top line data relating to the clinical trials on ...

Obstructive sleep apnea is caused by the collapse of the upper airway during sleep. The muscles supporting soft tissues in the throat relax, narrowing or closing the airway and temporarily ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates ...

China: A recent study published in the Journal of the American Heart Association has unveiled a compelling association ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...

Study reveals that sleep traits predict over 15% of body characteristics across 15 physiological systems, with visceral fat, ...

Turkey: A recent study published in The Laryngoscope revealed a significant relationship between laryngopharyngeal reflux ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...